22nd Century Group has filed a notice of an exempt offering of securities to raise $4,200,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, 22nd Century Group is raising up to $4,200,000.00 in new funding. Sources indicate that as part of senior management Director, Andy Arno played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About 22nd Century Group
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
To learn more about 22nd Century Group, visit http://xxiicentury.com/
Contact:
Andy Arno, Director
716-270-1523
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.